The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987.

Journal Article (Journal Article)

A nationwide survey to monitor the susceptibility of the Bacteroides fragilis group, which began in 1981, was continued during 1987. In addition to the eleven drugs evaluated in 1986, sulbactam, a potent beta-lactamase inhibitor, was tested alone and in combination with ampicillin and cefoperazone. Imipenem, ampicillin/sulbactam, cefoperazone/sulbactam, and ticarcillin/clavulanic acid were the most active newer drugs tested, with less than 1% resistance rates. Chloramphenicol, metronidazole and clindamycin also had excellent activity with resistance rates of 0%, 0%, and 3% respectively. Resistance rates to cefoxitin remained stable at 8%. Ceftizoxime and cefotetan had resistance rates of 26% and 29%, respectively. Rates of resistance varied among different institutions and between the various species.

Full Text

Duke Authors

Cited Authors

  • Cornick, NA; Cuchural, GJ; Snydman, DR; Jacobus, NV; Iannini, P; Hill, G; Cleary, T; O'Keefe, JP; Pierson, C; Finegold, SM

Published Date

  • June 1990

Published In

Volume / Issue

  • 25 / 6

Start / End Page

  • 1011 - 1019

PubMed ID

  • 2370237

International Standard Serial Number (ISSN)

  • 0305-7453

Digital Object Identifier (DOI)

  • 10.1093/jac/25.6.1011


  • eng

Conference Location

  • England